"Designing Growth Strategies is in our DNA"

Infectious Disease Point-of-care (POC) Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Technique (Lateral Flow Immunoassay, Agglutination Test), By Disease (HIV, Hepatitis B Virus, Respiratory Syncytial Virus, Influenza, Clostridium Difficile Infections), By Disease, COVID-19 Point-of-care (POC) Diagnostics, By End User (Hospital Bedside, Physicians Office Lab, Urgent Care & Retail Clinics), Regional Forecast, 2021-2028

The global infectious disease point-of-care diagnostics market size was USD 1.12 billion in 2020. The global impact of COVID-19 has been unprecedented and staggering, wit... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : Global | Published Date: Aug, 2021 | Report ID: FBI104307 | Status : Published

 

Request Sample PDF

Refresh Button
Infectious Disease Point-of-care (POC) Diagnostics Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2020
  • 2017-2019
  • 180
  • Direct Purchase
  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X